Global Pharmaceuticals & Biotech Most Popular Stocks

CRISM Therapeutics

Market Cap: UK£3.8m

Develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs.

Argent BioPharma

Market Cap: AU$7.8m

A clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally.

ECS Botanics Holdings

Market Cap: AU$7.8m

Engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally.

Mountain Valley MD Holdings

Market Cap: CA$7.0m

A biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada.

Xenetic Biosciences

Market Cap: US$5.0m

A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.

CNS Pharmaceuticals

Market Cap: US$5.0m

A clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors.

Stem Cells Spin

Market Cap: zł18.1m

Operates as a biotechnology company in Poland.

Rua Bioscience

Market Cap: NZ$8.6m

Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.

ANG Lifesciences India

Market Cap: ₹438.4m

Engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally.

Onconetix

Market Cap: US$4.9m

A biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United States, European Union, and Non-European Union.

Vivimed Labs

Market Cap: ₹410.4m

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India.

WEED

Market Cap: US$4.9m

Focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.

Samsrita Labs

Market Cap: ₹433.2m

Operates as a biopharmaceutical company in India.

GRI Bio

Market Cap: US$4.9m

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States.

Quest PharmaTech

Market Cap: CA$6.8m

A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.

Kabra Drugs

Market Cap: ₹425.8m

Does not have significant operations.

Sweet Earth Holdings

Market Cap: CA$6.6m

Does not have significant operations.

ExpreS2ion Biotech Holding

Market Cap: SEK 44.9m

A biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally.

Purple Biotech

Market Cap: ₪15.9m

A clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.

Bounce Mobile Systems

Market Cap: US$4.7m

Delex Healthcare Group, Inc. engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.

Apures

Market Cap: ₩6.7b

Engages in the development and commercialization of solutions for the bio and medical industries in South Korea.

Epsilon Healthcare

Market Cap: AU$7.2m

Operates as a healthcare and pharmaceuticals company primarily in Australia.

AItheNutrigene

Market Cap: ₩6.7b

Provides test-detection solutions for early detection and and prevention of diseases.

JFL Life Sciences

Market Cap: ₹419.0m

Manufactures and sells pharmaceutical products in India and internationally.

GP Solutions

Market Cap: US$4.7m

Provides growing systems for growing specialty and leaf crops, and herbs.

BerGenBio

Market Cap: NOK 46.9m

A clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory disease in Norway.

Revive Therapeutics

Market Cap: CA$6.5m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

National Graphite

Market Cap: US$4.6m

Through its subsidiary, Biotech Development Corp., operates as a biopharmaceutical risk/cost-sharing company.

Valeo Pharma

Market Cap: US$4.6m

A specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceuticals and hospital specialty products for unmet medical needs in Canada.

Roquefort Therapeutics

Market Cap: UK£3.4m

A material biotech company, engages in the development of medicines for the treatment of cancer.

Plandaí Biotechnology

Market Cap: US$4.5m

Focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries.

Delivra Health Brands

Market Cap: CA$6.3m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

CanadaBis Capital

Market Cap: CA$6.2m

Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.

Jaguar Health

Market Cap: US$4.5m

A commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.

XORTX Therapeutics

Market Cap: CA$6.2m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

Shuttle Pharmaceuticals Holdings

Market Cap: US$4.4m

A clinical stage pharmaceutical company, develops novel therapies to cure cancers.